132 related articles for article (PubMed ID: 9768876)
1. Slide-binding characterization and autoradiographic localization of delta opioid receptors in rat and mouse brains with the tetrapeptide antagonist [3H]TIPP.
Bakota L; Szikra J; Toth G; Gulya K
Life Sci; 1998; 63(15):1377-85. PubMed ID: 9768876
[TBL] [Abstract][Full Text] [Related]
2. TIPP[psi], a highly selective delta ligand.
Visconti LM; Standifer KM; Schiller PW; Pasternak GW
Neurosci Lett; 1994 Nov; 181(1-2):47-9. PubMed ID: 7898768
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and binding characteristics of tritiated TIPP[psi], a highly specific and stable delta opioid antagonist.
Nevin ST; Tóth G; Weltrowska G; Schiller PW; Borsodi A
Life Sci; 1995; 56(10):PL225-30. PubMed ID: 7885186
[TBL] [Abstract][Full Text] [Related]
4. Light microscopic autoradiographic localization of delta opioid receptors in the rat brain using a highly selective bis-penicillamine cyclic enkephalin analog.
Gulya K; Gehlert DR; Wamsley JK; Mosberg H; Hruby VJ; Yamamura HI
J Pharmacol Exp Ther; 1986 Aug; 238(2):720-6. PubMed ID: 3016247
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and binding characteristics of the highly specific, tritiated delta opioid antagonist [3H]TIPP.
Nevin ST; Toth G; Nguyen TM; Schiller PW; Borsodi A
Life Sci; 1993; 53(5):PL57-62. PubMed ID: 8393120
[TBL] [Abstract][Full Text] [Related]
6. Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity.
Fang L; Knapp RJ; Horvath R; Matsunaga TO; Haaseth RC; Hruby VJ; Porreca F; Yamamura HI
J Pharmacol Exp Ther; 1994 Feb; 268(2):836-46. PubMed ID: 8113996
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine-iodination converts the delta-opioid peptide antagonist TIPP to an agonist.
Lee PH; Nguyen TM; Chung NN; Schiller PW; Chang KJ
Eur J Pharmacol; 1995 Jul; 280(2):211-4. PubMed ID: 7589188
[TBL] [Abstract][Full Text] [Related]
8. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ
Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574
[TBL] [Abstract][Full Text] [Related]
10. Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography.
Dissanayake VU; Hughes J; Hunter JC
Mol Pharmacol; 1991 Jul; 40(1):93-100. PubMed ID: 1649966
[TBL] [Abstract][Full Text] [Related]
11. Agonist Activity of the delta-antagonists TIPP and TIPP-psi in cellular models expressing endogenous or transfected delta-opioid receptors.
Martin NA; Terruso MT; Prather PL
J Pharmacol Exp Ther; 2001 Jul; 298(1):240-8. PubMed ID: 11408548
[TBL] [Abstract][Full Text] [Related]
12. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
Liu-Chen LY; Yang HH; Li S; Adams JU
J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
[TBL] [Abstract][Full Text] [Related]
13. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
Cao YJ; Bian JT; Bhargava HN
Eur J Pharmacol; 1997 Sep; 335(2-3):161-6. PubMed ID: 9369369
[TBL] [Abstract][Full Text] [Related]
14. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
Tourwé D; Mannekens E; Diem TN; Verheyden P; Jaspers H; Tóth G; Péter A; Kertész I; Török G; Chung NN; Schiller PW
J Med Chem; 1998 Dec; 41(26):5167-76. PubMed ID: 9857087
[TBL] [Abstract][Full Text] [Related]
15. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
16. delta-Opioid receptor binding in mouse brain: evidence for heterogeneous binding sites.
Sofuoglu M; Portoghese PS; Takemori AE
Eur J Pharmacol; 1992 Jun; 216(2):273-7. PubMed ID: 1327813
[TBL] [Abstract][Full Text] [Related]
17. Agonist, antagonist, and inverse agonist characteristics of TIPP (H-Tyr-Tic-Phe-Phe-OH), a selective delta-opioid receptor ligand.
Martin NA; Ruckle MB; VanHoof SL; Prather PL
J Pharmacol Exp Ther; 2002 May; 301(2):661-71. PubMed ID: 11961071
[TBL] [Abstract][Full Text] [Related]
18. Single diastereomeric desaminotyrosylalanyl tetra- and heptapeptides with opioid antagonistic activity.
Balboni G; Salvadori S; D'Angeli F; Marchetti P; Lazarus LH; Bryant SD; Bianchi C
Int J Pept Protein Res; 1995 Feb; 45(2):187-93. PubMed ID: 7782167
[TBL] [Abstract][Full Text] [Related]
19. [3H]naltrindole: a potent and selective ligand for labeling delta-opioid receptors.
Contreras PC; Tam L; Drower E; Rafferty MF
Brain Res; 1993 Feb; 604(1-2):160-4. PubMed ID: 8384509
[TBL] [Abstract][Full Text] [Related]
20. Postnatal development of delta-opioid receptor subtypes in mice.
Negri L; Severini C; Lattanzi R; Potenza RL; Melchiorri P
Br J Pharmacol; 1997 Mar; 120(6):989-94. PubMed ID: 9134207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]